Damage to skin tissue from refractory wounds, surgical procedures and injury
represents a growing healthcare need. Shifting demographics will drive
industry growth in the years ahead as an aging population provides further
stimulus for tissue repair demand. Tissue engineering is now an emerging
industry with research and development taking place in the world's leading
universities and companies worldwide. Emerging products and processes for
wound management and tissue repair include a number of synthetic and
bioengineered products that have recently become available, or are being
developed, as adjuncts to wound care and/or as a replacement for human skin.
- Analyzes and evaluates the new generation of tissue-engineered and
biologically active technologies and products for replacing or augmenting
damaged or diseased skin
- Provides detailed analysis of bioengineered skin substitute products
- Assesses business risk factors and market issues
- Analyzes technology and product developments, and provides forecasts
- Profiles bioengineered skin substitute companies, their product
development activities, and strategies
What You Will Learn
- What are the key segments and patient demographics that comprise the
market for engineered skin substitutes?
- What are the major therapeutic demand drivers for bioengineered skin
- What are the design factors, material selection issues and technologies
that are being used in commercial and development-stage engineered skin
- What is the market share and product position in the market and what will
it look like in 2018?
- Who are the companies behind the current generation of bioengineered skin
substitutes and what are their business models?
- What is the role of pharma-device alliances and design partnerships in the
commercialization and market access of new and emerging bioengineered skin
- What is the impact of economic, technology, and regulatory factors?